Objective: To assess the role native nephrectomy (NN) in hypertension-related outcomes for pediatric patients undergoing renal transplantation (RT).
Methods: Renal transplants (RT) performed at our institution between 2006 and 2015 were reviewed. RT recipients who underwent NN were compared to those who did not. Primary outcomes were hypertension-related: use/number of medications pre-/post-transplant and hypertension-related readmissions. Secondary outcomes were 1-year outcomes of: readmissions, eGFR, Clavien-Dindo classification ≥ 3 complications, and graft loss.
Results: 135 patients were evaluated. 24 underwent NN (Group 1) and 111 did not (Group 2). Baseline characteristics were similar between Groups 1 and 2. The majority of NN indications were hypertension (10/39 kidneys) and proteinuria (12/39 kidneys). There were no differences in use/number of anti-hypertensive medications pre- or post-transplant. However, between Group 2 and subgroup of patients who underwent NN for hypertension, a significant difference was seen in medication use/numbers but not post-transplant. Number of readmissions due to hypertension was similar (7.2% vs. 12.5%). The only difference in secondary outcomes was higher readmission rates with bacterial infections for group 1 (45.8% vs. 23.4%, p = 0.041).
Conclusion: NN, when offered to patients at higher risk of post-RT hypertension, may allow high-risk patients to achieve similar hypertension outcomes as those at lower risk.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00383-022-05080-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical characteristics and outcomes of kidney transplantation in autosomal dominant polycystic kidney disease patients.
J Nephrol
November 2024
Division of Nephrology, Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, Republic of Korea.
Article Synopsis
- Kidney transplantation is the best treatment option for autosomal dominant polycystic kidney disease (ADPKD), and this study compares the clinical outcomes of ADPKD patients to non-ADPKD kidney transplant recipients.
- The research analyzed data from two Korean transplant centers over 15 years and found that ADPKD patients had a higher risk of developing post-transplant diabetes and infections, although their rates of rejection, graft failure, and mortality were similar to non-ADPKD patients.
- Interestingly, while kidney volume decreased after transplantation, the size of liver cysts increased in ADPKD patients, indicating that kidney size and prior surgeries did not affect overall transplant outcomes.
High grade renal cell carcinoma in a simultaneous pancreas and kidney transplant recipient.
Int J Surg Case Rep
November 2024
Beaumont Hospital, Dublin, Ireland.
Introduction And Importance: Renal transplant recipients have a higher risk for developing cancers compared to the general population due to high-dose immunosuppression. The risk of renal cell carcinoma (RCC) in native kidneys is 7-fold greater than the general population and development of RCC in an allograft kidney is extremely rare. We report the diagnosis and management of a large RCC in an allograft renal transplant and metastatic disease in a regional lymph node.
View Article and Find Full Text PDFExperiences of Unanticipated Outcomes Among Ethnically Diverse Living Kidney Donors: A Qualitative Pilot Study.
Clin Transplant
October 2024
University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, USA.
Introduction: Although living kidney donation is generally considered a safe procedure, it is ethically critical that prospective donors are fully informed before consent. However, prospective donors lack a deep understanding of the donation experience, making the postdonation aftermath feel unanticipated. We sought to gain in-depth qualitative descriptions of the short- and long-term risks and benefits associated with kidney donation among an ethnically diverse group of donors to offer a balanced view of the positive and negative experiences that may occur postdonation.
View Article and Find Full Text PDFNative nephrectomy in patients with autosomal dominant polycystic kidney disease in kidney transplant program: long-term single-center experience.
Int Urol Nephrol
October 2024
Charles University, Faculty of Medicine in Hradec Kralove, Hradec Králové, Czech Republic.
Article Synopsis
- Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder often leading to end-stage renal disease, and this study reviews native nephrectomy (NN) practices over 25 years at a transplant center.
- A total of 89 out of 152 ADPKD patients who underwent kidney transplantation (KT) also had NN, with most NN being unilateral and planned surgeries showing better outcomes than acute ones.
- The findings highlight the importance of careful planning and patient-specific strategies in NN for ADPKD due to increased complications associated with acute surgeries.
Incidental renal cell carcinoma post bilateral nephrectomy in autosomal dominant polycystic kidney disease.
World J Clin Cases
October 2024
Division of General Surgery, Department of Hepato-Bilio-Pancreatic Surgery and Transplantation Surgery, Chosun University College of Medicine, Gwangju 61453, South Korea.
Background: Renal cell carcinoma (RCC) is more common in patients with autosomal dominant polycystic kidney disease (ADPKD) than in the general population. Diagnosing RCC in ADPKD is challenging due to the presence of multiple renal cysts, often leading to delays and difficulties in distinguishing RCC from cyst infection or hemorrhage.
Aim: To analyze the prevalence and characterize the clinical features of RCC in patients with ADPKD undergoing simultaneous bilateral native nephrectomy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!